Cargando…
The research domain criteria framework in drug discovery for neuropsychiatric diseases: focus on negative valence
Drug discovery, particularly in the field of central nervous system, has had very limited success in the last few decades. A likely contributor is the poor translation between preclinical and clinical phases. The Research Domain Criteria of the National Institutes of Mental Health is a framework whi...
Autores principales: | Nicholson, Janet R., Sommer, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058263/ https://www.ncbi.nlm.nih.gov/pubmed/32166151 http://dx.doi.org/10.1177/2398212818804030 |
Ejemplares similares
-
Mood and anxiety disorders within the Research Domain Criteria framework of Positive and Negative Valence Systems: a scoping review
por: Böttger, Sarah Jane, et al.
Publicado: (2023) -
Adaptation of Threat Responses Within the Negative Valence Framework
por: Smith, Nancy J., et al.
Publicado: (2022) -
Angelman syndrome in three biological siblings: Focusing on the neuropsychiatric domain
por: Panda, Akhila Kumar, et al.
Publicado: (2013) -
Editorial: Negative valence systems
por: Honeycutt, Jennifer A., et al.
Publicado: (2022) -
Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery
por: Henry, Jason, et al.
Publicado: (2019)